Investors Overview
We’re Delivery the Promise of Healthier Lives.
Our Company
Corporate Profile
CURE has an FDA-registered, cGMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform which includes CUREfilm®, one of the most advanced oral thin films on the market today; CUREpods™ a novel chewable delivery system and other more traditional dose forms that use advanced encapsulation technology. CUREform’s combined technologies provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. CURE also holds the NSF® cGMP certification for manufacturing dietary supplements.
CURE’s clinical pipeline includes CUREfilm® Blue (sildenafil to treat erectile dysfunction), and CUREfilm® Canna (THC and CBD) each designed to optimize the pharmacokinetic profile of the medicine.
CURE partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S.A, Canada, Israel, and other markets.
Cure Pharmaceutical Corporation was founded in July 2011 and is a wholly-owned subsidiary of Cure Pharmaceutical Holding Corp, a public company.
Stock Today
Headquarters
CURE Pharmaceutical
1620 Beacon Place
Oxnard, CA 93033
Phone:
Fax:

We are positioned to advance numerous therapeutic categories, including pharmaceutical cannabis.
Cure Pharmaceutical
Our Investor Presentation

Media
Recent Videos
CURE Pharmaceutical Investor
Video Webcast | Dec. 17 2020
CBD, Cannabis and the Cannabiz
In the news
Press Releases
CURE Pharmaceutical Announces Promotions and Additions to Board of Directors
OXNARD, Calif. - CURE Pharmaceutical Holdings ("CURE" or the "Company") (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today updates and additions to its Board of Directors. After...
Sera Labs Unveils ImmunD₃™ an Important New Offering to the Nutri-Strips™ Product Line; Launches New Digital E-commerce Website to Amplify Consumer Awareness
Sera Labs Pioneers the Delivery of Next Generation Immune Support in the Continued Battle Against the COVID-19 Pandemic LOS ANGELES & OXNARD, Calif. - According to the National Institute of Health (NIH) more than 50 percent of people worldwide have Vitamin D...
Sera Labs, Inc. Wins Prestigious Retail Excellence Award
Health, Wellness, CBD and plant-based anti-aging skincare powerhouse, Sera Labs wins Drug Store News' annual Natural Products Award LOS ANGELES & OXNARD, Calif. - The retailers have spoken! Sera Labs, Inc., the wholly owned subsidiary of CURE Pharmaceutical...
CURE Pharmaceutical to Present at 2021 NobleCon17 on Tuesday, January 19 at 3pm EST/12pm PST
OXNARD, Calif. - CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company's Chief Executive Officer...
CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference
OXNARD, Calif. - CURE Pharmaceutical Holding Corp ("CURE" or the "Company") (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company's...
CURE Pharmaceutical Receives FDA Approval for its IND Application for Erectile Dysfunction Product CUREfilm Blue™
OXNARD, Calif. - CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the U.S....
Management Team
Board of Directors
Robert Davidson
Chief Executive Officer, Director
Michael Redard
Chief Financial Officer
Nancy Duitch
Chief Strategic Officer and Director; CEO of Wholly owned subsidiary, The Sera Labs
Vered Gigi
Chief Scientific Officer
Mark Udell
Chief Accounting Officer
Jonathan Berlent
Chief Business Officer
Donna Hudson
Vice President of Quality and Compliance Systems
Ruben King-Shaw Jr.
Chairman of the Board
Robert Davidson
Chief Executive Officer, Director
Nancy Duitch
Chief Strategic Officer and Director, CEO of Wholly owned subsidiary, The Sera Labs.
Lauren Chung, Ph.D
Director
Anya Goldin
Director
Joshua Held
Director
Gene Salkind, MD
Director
William Yuan
Chairman Emeritus
Key Contacts
Corporate Counsel
K&L Gates
10100 Santa Monica Blvd., 8th Fl.
Los Angeles, CA 90067